| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA358033
Max Phase: Preclinical
Molecular Formula: C27H27ClN2O
Molecular Weight: 430.98
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(N[C@@H]1C2CCN(CC2)[C@@H]1C(c1ccccc1)c1ccccc1)c1ccccc1Cl
Standard InChI: InChI=1S/C27H27ClN2O/c28-23-14-8-7-13-22(23)27(31)29-25-21-15-17-30(18-16-21)26(25)24(19-9-3-1-4-10-19)20-11-5-2-6-12-20/h1-14,21,24-26H,15-18H2,(H,29,31)/t25-,26-/m1/s1
Standard InChI Key: YECFTEONBCBTGK-CLJLJLNGSA-N
Associated Targets(Human)
Neurokinin 1 receptor 6273 Activities
Associated Targets(non-human)
Neurokinin 1 receptor 881 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Neurokinin 1 receptor 938 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Neurokinin 2 receptor 128 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Neurokinin 3 receptor 158 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 430.98 | Molecular Weight (Monoisotopic): 430.1812 | AlogP: 5.36 | #Rotatable Bonds: 5 |
| Polar Surface Area: 32.34 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
| #RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 13.70 | CX Basic pKa: 8.74 | CX LogP: 5.60 | CX LogD: 4.25 |
| Aromatic Rings: 3 | Heavy Atoms: 31 | QED Weighted: 0.59 | Np Likeness Score: -0.30 |
References
| 1. Howson W, Hodgson J, Richardson R, Walton L, Guard S, Watling K. (1992) An SAR study for the non-peptide substance P receptor (NK1) antagonist, CP-96,345., 2 (6): [10.1016/S0960-894X(01)81197-5] |
Source
Source(1):